Posted on 1 月 14, 20211/14/21
BMS, Roche, AZ Lose Out as China Favors Domestic Companies in 2020 NRDL PD-1 Bid
Posted on 1 月 4, 20211/4/21
China Issues 2020 National Reimbursement Drug List
Posted on 8 月 19, 20208/19/20
China Publishes Working Plan for 2020 NRDL Update, Revised List Expected December 2020
Posted on 6 月 7, 20206/7/20
Canada Publishes Budget Impact Analysis Guidelines Under New PMPRB Amendments
Posted on 5 月 4, 20205/4/20
Pricentric Insights: China’s Interim Measures for NRDL, BMI Administration
Posted on 3 月 9, 20203/9/20
Vertex & Canada Pricing Alliance Back-and-Forth on CF Drug Reimbursement
Posted on 1 月 27, 20201/27/20